Federal lawsuits claiming that the eczema and asthma drug Dupixent caused users to develop a form of skin cancer have been gathered before a single judge. On June 4, 2026, the U.S. Judicial Panel on Multidistrict Litigation centralized the cases into a new...
Investigating the Link Between Depo-Provera and Benign Brain Tumors (Meningiomas) At Rudolph F.X. Migliore, P.C., we have long been at the forefront of advocating for individuals harmed by defective or dangerous products. Our latest investigation focuses on...
A second carcinogen was discovered in the blood pressure and heart failure medication, valsartan. The FDA issued a recall in July 2018 when some batches of valsartan were found to contain N- Nitrosodimethylamine (NDMA), a known carcinogen. Recently, however, the FDA...
Onglyza is a Type 2 diabetes medication that lowers blood sugar by increasing the level of insulin after a meal. The medication’s active ingredient is saxagliptin and it belongs to a class of drugs known as DPP-4 inhibitors. DPP-4 inhibitors were found to cause...
Valsartan is a medication used to treat hypertension and heart failure. It can also lower the risk of death after a heart attack. The medication lowers blood pressure by preventing blood vessels from narrowing. Valsartan has been on the market for 15 years and has...
The Law Offices of Rudolph F.X. Migliore, P.C. represents clients in Nassau and Suffolk County, across Long Island, and throughout the New York City area. The firm has more than three decades of experience in personal injury, mass tort, and criminal defense matters, and draws on a nationwide co-counsel network when a case calls for it.
Call (631) 543-3663 anytime to arrange a free consultation.
